» Articles » PMID: 15764154

Adhesion Molecules As a Prognostic Marker of Liver Cirrhosis

Overview
Publisher Informa Healthcare
Specialty Gastroenterology
Date 2005 Mar 15
PMID 15764154
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Endothelial activation plays an active role in modifications of the circulatory status of cirrhotic patients. Soluble endothelial adhesion molecules, induced by pro-inflammatory cytokines, could be considered markers of endothelial activation. Their role in the natural history of cirrhosis and portal hypertension has not been reported. Our objective was to analyze the prognostic value of soluble adhesion molecules in cirrhotic patients.

Material And Methods: Serum concentrations of soluble CD14, soluble receptors of tumor necrosis factor alpha and adhesion molecules ICAM-1 (intercellular adhesion molecule-1) and VCAM-1 (vascular cell adhesion molecule 1) as well as mean blood pressure, plasma renin activity, aldosterone, vasopressin and norepinephrine concentrations were determined in 64 cirrhotic patients (Child-Pugh class: A 48.4%, B 34.4%, C 17.2%), without any evidence of infection, and in 25 healthy controls. Patients were followed-up for a mean of 36.4 (range 6-60) months.

Results: Increased concentrations of soluble CD14, tumor necrosis factor receptors and ICAM-1 and VCAM-1 were detected in cirrhotic patients when compared with healthy controls. Tumor necrosis factor receptors and adhesion molecule concentrations were both significantly higher in advanced phases of cirrhosis (Child Pugh class C and B versus A). Fifteen patients died as a related consequence of liver cirrhosis. Multivariate analysis demonstrated that Child-Pugh score and serum levels of tumor necrosis factor receptor I and ICAM-1 were associated with mortality.

Conclusions: In addition to the classic factor implicated in mortality (Child-Pugh class), alterations in inflammation-related components and soluble adhesion molecules, as representatives of hemodynamic alterations, are of prognostic significance in cirrhotic patients.

Citing Articles

Serum Vascular Adhesion Protein-1 and Endothelial Dysfunction in Hepatic Cirrhosis: Searching for New Prognostic Markers.

Fasolato S, Bonaiuto E, Rossetto M, Vanzani P, Ceccato F, Vittadello F Int J Mol Sci. 2024; 25(13).

PMID: 39000418 PMC: 11242677. DOI: 10.3390/ijms25137309.


Endothelial and microvascular function in liver cirrhosis: an old concept that needs re-evaluation?.

Papagiouvanni I, Sarafidis P, Theodorakopoulou M, Sinakos E, Goulis I Ann Gastroenterol. 2022; 35(5):471-482.

PMID: 36061155 PMC: 9399579. DOI: 10.20524/aog.2022.0734.


Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis.

Kar S, Paglialunga S, Jaycox S, Islam R, Paredes A PLoS One. 2019; 14(7):e0217263.

PMID: 31291245 PMC: 6619600. DOI: 10.1371/journal.pone.0217263.


Selective Intestinal Decontamination in Portal Hypertension.

Kemp W, Chin-Dusting J Gastroenterol Hepatol (N Y). 2017; 2(1):64-67.

PMID: 28210199 PMC: 5307264.


Down-regulation of common NFκB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary Cirrhosis.

Li T, Lee P, Lee K, Hsieh Y, Tsai C, Yang Y Sci Rep. 2016; 6:39405.

PMID: 28009008 PMC: 5180197. DOI: 10.1038/srep39405.